Effective low–dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach–Merritt phenomenon in young infants

AIMS: Management of kaposiform haemangioendotheliomas (KHE) with Kasabach–Merritt phenomenon is challenging in young infants who are subjected to developmental pharmacokinetic changes. Sirolimus, sometimes combined with corticosteroids, can be used as an effective treatment of KHE. Simultaneously, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Harbers, Veroniek E. M., van der Salm, Nathalie, Pegge, Sjoert A. H., van der Vleuten, Carine J. M., Verhoeven, Bas H., Vrancken, Sabine L. A. G., Schultze Kool, Leo J., Fuijkschot, Joris, te Loo, D. Maroeska M. W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303919/
https://www.ncbi.nlm.nih.gov/pubmed/34957601
http://dx.doi.org/10.1111/bcp.15202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303919/
https://www.ncbi.nlm.nih.gov/pubmed/34957601
http://dx.doi.org/10.1111/bcp.15202

Ejemplares similares